14th European Headache Federation Congress

Head over Ache: Silver Lining Novel Treatments
July 3–5, 2020 • Berlin, Germany

Congress details

Sponsors

Platin Sponsors

Eli Lilly and Company
Indianapolis, IN/US

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.


Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 43,000 professionals, committed to improving the lives of millions of patients. Learn more at www.tevapharm.com.


Gold Sponsor

Allergan AG
Dublin/IE

Allergan plc is a bold, global biopharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

In neurosciences and mental health, Allergan has developed and markets treatments for cerebral palsy, post-stroke spasticity, chronic migraine, Alzheimer’s disease, bipolar disorder and schizophrenia. Allergan also has treatments in clinical development for Alzheimer’s disease, migraine, major depression and Parkinson’s disease.